Inclusion Criteria:~Inclusion Criteria for the Subjects with early Alzheimer's Disease (AD)~* Age 50-90 years
old.~* On a stable dose of medications for memory loss including cholinesterase inhibitors (for example:
donepezil, rivastigmine or memantine) as defined by 4 consecutive weeks of treatment at an unchanging dose~*
Meeting the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's
Disease and Related Disorders Association (NINCDS-ADRDA) criteria for probable AD.~* Mini Mental State
Examination (MMSE) â‰¥ 20.~* Positive amyloid status (as defined by cerebral spinal fluid biomarkers or amyloid
positron emission tomography (PET) study.~* Clinician Dementia Rating (CDR) of 0.5-1.0.~Inclusion Criteria for
Healthy Control Subjects~* Age 50-90 years old.~* Normal neurologic exam~* Mini Mental State Examination (MMSE)
> 28~* Clinician Dementia Rating (CDR) of 0~
